Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas

This study is currently recruiting participants.
Verified August 2012 by Peking Union Medical College Hospital
Sponsor:
Collaborators:
Beijing Tiantan Hospital
Tianjin Medical University General Hospital
Information provided by (Responsible Party):
Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT01670890
First received: August 19, 2012
Last updated: August 21, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)